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ScienceDirectSignificant developments and improvements in basic and
clinical research notwithstanding, infectious diseases still claim
at least 13 million lives annually. Classical research approaches
have deciphered many molecular mechanisms underlying
infection. Today it is increasingly recognized that multiple
molecular mechanisms cooperate to constitute a complex
system that is used by a given pathogen to interfere with the
biochemical processes of the host. Therefore, systems-level
approaches now complement the standard molecular biology
techniques to investigate pathogens and their interactions
with the human host. Here we review omic studies in
Mycobacterium tuberculosis, the causative agent of
tuberculosis, with a particular focus on proteomic methods and
their application to the bacilli. Likewise, the discussed methods
are directly portable to other bacterial pathogens.
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Introduction
Thirty six years ago, improvement in hygiene and nutri-
tion as well as the development of new drugs and vaccines
conferred a dominant thought that infectious diseases are
close to becoming insignificant [1]. However, due to the
persistence of serious infectious diseases the death rate
attributed to infection now stands at 13–15 million people
per year and will continue as such at least until 2030 [2].
Mycobacterium tuberculosis (Mtb) is the leading cause ofCurrent Opinion in Microbiology 2017, 39:64–72 mortality among infectious diseases and claims 1.8 million
lives annually. Macrophages recognize and engulf the
bacilli following infection but cannot thoroughly clear them,
making Mtb difficult to treat. Mtb achieve this intracellular
state by modulating the immune and other cellular systems
at various levels. For instance, Mtb partially blocks phago-
somal acidification, a prerequisite for phagosomal rupture,
and lysosome–phagosome fusion following uptake by
macrophages [3]. A growing body of evidence suggests that
the strategy applied by a pathogen such as Mtb to subvert
the human host involves multiple mechanisms and that
systems-level studies are indispensable to study them. In
the Mtb field, the vast majority of effort in systems-level
analyses have been focused on genomic and functional
genomics studies. Yet, proteins are the main functional
elements of biochemical pathways, thus determining phe-
notypic traits. The state of the proteome of a cell is
therefore expected to provide more direct functional infor-
mation than genomic analyses alone. Over the past decade,
new proteomic methods and tools have been developed
that now support the quantification of proteins systemati-
cally and reproducibly over many samples, thus facilitating
systems-level studies at the level of the proteome.
Lessons from genetic and transcriptional
studies of Mtb
Mtb, as an intracellular pathogen has a GC rich genome of
4.4 million base pairs that contains 4018 protein coding
genes. The genome was initially sequenced in 1998 [4].
Strikingly, 26% of the Mtb genes, called leaderless genes,
lack 50UTR and hence the Shine-Dalgarno sequence
commonly used for the initialization of ribosome engage-
ment [5]. The general lack of genetic recombination in
bacteria and horizontal gene transfer keep the Mtb
genome in complete linkage [6,7]. Advances in DNA
sequencing throughput and affordability paved the way
to explore the diversity and evolution of the bacilli with
respect to the human host. Genomic results from clinical
cohort studies suggest that Mtb has co-evolved, migrated
and expanded within the human host, since its origin in
Africa [8]. To date, Mtb’s phylogenetic dendrogram
comprises seven lineages of strains infecting humans.
They are associated with different geographical regions,
with any two strains differing by 1200 SNPs on average
[9]. Contrary to the situation in many other bacteria, about
two thirds of the SNPs of Mtb in the coding regions are
non-synonymous and more than half fall into highly
conserved positions, hinting that the majority of thewww.sciencedirect.com
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the phenotypic diversity of the pathogen [10,11]. Clinical
isolates of Mtb feature diverse phenotypes in response to
the host [7,12]. Despite the fact that pathogens usually
carry variable antigens to evade the host immune system,
human T-cell epitopes in Mtb are highly conserved,
suggesting that lung damage during tuberculosis might
be largely caused by the host immune response which
increases patient coughing and eventually facilitates the
transmission of the pathogen. Genome-wide association
studies (GWAS) together with standard molecular biology
techniques identified the most common causative muta-
tions conveying resistance to at least 16 different drugs
[13,14,15,16]. Also, recently, a genomic study on
5310 Mtb genomes elucidated that the katG mutation
encoding p.S315T, which confers resistance to isoniazid,
overwhelmingly arises before causative mutations of
rifampicin resistance across all the lineages. In spite of
these and other successes of genomic studies, it remains
challenging to derive detailed molecular mechanisms of
infection and persistence from such data alone.
In addition to large-scale genome sequencing efforts
Mtb researchers have turned to functional genomic ap-
proaches, primarily mRNA analysis by microarrays or
RNA sequencing following perturbation experiments to
increase systems level understanding. For example, Mtb
can effectively respond to stresses such as hypoxia and
remain in a non-replicating state called dormancy, even
for decades. The dormant state of Mtb introduces a
marked phenotypic drug resistance and its persistence
within the host. Sherman and colleagues used transcrip-
tome analyses to demonstrate that a transcription factor,
DosR (Rv3133c), regulates 50 genes in the so-called
DosR regulon in response to hypoxia [17,18]. This first
effort was followed by a larger study where they mapped
the transcriptional network of Mtb using ChIPSeq com-
bined with expression data from the induction of the same
transcription factors [19,20]. The data revealed Rv0081 as
one of the largest hubs orchestrating the transcriptional
network in hypoxic stress [21]. A related study showed
the significance of two transcription factors, Rv0324 and
Rv0880, in pushing Mtb into a tolerant state following the
treatment with the antitubercular drug bedaquiline [22].
However, some regulatory mechanisms are not apparent
from transcriptional results. For instance, the vaccine
strain of Mtb, BCG, modifies 40 ribonucleosides in tRNA
in response to hypoxia which results in the selective trans-
lation of mRNAs from families of codon-biased persistence
genes [23]. Although Mtb exposed to nitric oxide stress
respond rapidly at the transcriptome level, it takes some
time of these changes to be revealed on protein level, a
behavior that has been linked to protein degradation rather
than proteins synthesis [24]. It has therefore been suggested
that proteomic data should be integrated with results from
other large-scale biomolecular studies and specific func-
tional assays to generate mechanistic models of complexwww.sciencedirect.com processes. As a way of multi-omics data integration, genetic
association studies are portable to the transcriptome, meta-
bolome and proteome of a given organism to determine how
genomic variants translate into altered quantitative biomo-
lecular profiles that eventually determine phenotypic traits
[25,26,27,28].
Proteomics methods to provide mechanistic
insights in bacterial pathogens
Proteomics aims at characterizing the state of the prote-
ome across conditions and biological samples at a given
time point. It offers a wide variety of methods relying
primarily on liquid chromatography coupled to tandem
mass spectrometry (LC–MS/MS) to identify and quantify
proteins, their post-translational modifications (PTMs),
conformations and interactions [29]. Proteomics meth-
ods can be subdivided into two conceptual streams, top-
down and bottom-up proteomics. In the top-down
approach, molecular ions of the intact proteoform are
generated that are then fragmented within the mass
spectrometer for more extensive analyses. Bottom-up
proteomics, currently the dominant paradigm for most
proteomics applications, relies on the protein inference
logic where peptides originating from proteins following
digestion by a protease are identified and then mapped
back to proteins for both identification and quantification
(Figure 1a) [30]. After initially determining the mass to
charge ratio of molecular ions of peptides (MS1), they are
fragmented in a collision cell of a mass spectrometer and
the masses and intensities of fragment ions (MS2) are
determined. This information can then be used to iden-
tify the amino acid sequence of the peptide. In the last
20 years bottom-up proteomics has been dominated by
two approaches, referred to as discovery and targeted
proteomics [31]. In discovery proteomics the instrument
is operated in data dependent acquisition mode (DDA)
where the most intense peptide ions detected in MS1
scans are sequentially selected for fragmentation and
MS2 analysis. Discovery proteomics can identify and
quantify thousands of proteins over many conditions
and samples. However, given that precursor selection
for MS2 analysis occurs semi-stochastically in complex
samples, this can result in a considerable number of
missing values in the final quantitative data matrix if
multiple samples are being sequentially analyzed, alto-
gether impairing the reproducibility of results of cohort
studies (Figure 1b). In contrast, targeted proteomics
attempts to systematically acquire quantitative informa-
tion on a pre-specified set of proteins by directing the
mass spectrometer to deterministically acquire fragment
ion signals only for a predetermined set of peptides that
represent the proteins under investigation. This type of
measurement primarily relies on an MS acquisition mode
referred to as selected or multiple reaction monitoring, (S/
MRM), or a related method termed parallel reaction
monitoring (PRM), and allows the multiplexed analysis
of dozens to maximally hundreds of proteins. TargetingCurrent Opinion in Microbiology 2017, 39:64–72
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among the mass spectrometric strategies but are not
practically scalable to thousands of proteins. S/MRM
requires mass spectrometric and chromatographic coordi-
nates for the peptides of interest as prior knowledge to
direct the MS data acquisition and to score the resulting
data output (Figure 1c) [32,33]. In an effort to overcome
the limitations mentioned above several labs have more
recently developed methods based on an MS data acqui-
sition mode referred to as data independent acquisition
(DIA) in which many peptides are fragmented and ana-
lyzed in parallel. For example, SWATH-MS, an imple-
mentation of the DIA strategy, combines the strengths of
both aforementioned strategies, and can systematically
and reproducibly analyze up of thousands proteins across
various conditions and samples (Figure 1d) [31,34]. To
extract quantitative data from the highly complex and
convoluted fragment ion spectra generated by DIA/
SWATH-MS, prior knowledge about the fragmentation
properties of specific peptides is typically employed [35].
During the past years, custom computational tools have
been developed enabling chromatogram extraction
[36,37], false discovery rate control [38], protein quantifi-
cation [39], differential expression analysis [40,41] and
study of PTMs for SWATH-MS [42].
Overall, the developed proteomics workflows can com-
plement each other in the sense that each method is more
suitable for a given biological objective. For instance,
discovery proteomics (shotgun-MS) is a prerequisite for
targeted proteomic studies where there is no reliable
knowledge on the proteome of organism of interest. In
contrast, targeting methods (S/MRM) and DIA/SWATH-
MS are implemented to quantify proteins over a sample
cohort consistently and reproducibly. They do require
however, prior knowledge of the fragment ion spectra of
the targeted peptides.
Current knowledge about the proteome of
Mtb
A decade ago, shotgun-MS was the only viable mass
spectrometry-based proteomic method and consequently
most of the available proteomic data was in this form. In
addition to providing important insights into the compo-
sition of the respective sample, the resulting fragment ion
spectra provided the basis for specific measurement as-
says for targeting MS and DIA methods. This progression
from proteome discovery to serial proteome quantification(Figure 1 Legend) Schematic overview on bottom-up proteomics and its th
bottom-up proteomic study consisting of sample preparation, data acquisiti
between various proteomic methods is the data acquisition step and assoc
precursors (ionized peptides) are isolated for MS2 scan based on their inten
The final data matrix has a considerable amount of missing values. (c) S/MR
obtain chromatographic and mass spectrometric coordinates of peptides o
not rely on MS1 scans for isolating precursors, they are considered as data
range into several dozen windows and each time a subpopulation of precur
and eventually their MS2 scan is measured. In the data processing step, qu
www.sciencedirect.com by targeting MS and DIA methods has been robustly
implemented for Mtb. Specifically, Mtb is one of only a
few species for which reference fragment ion spectra
have been generated and made publicly accessible for
proteins from every ORF of the genome [43,44,45].
In the following, we discuss the biological insights into
the proteome of Mtb gained from different proteomic
methods.
Discovery of Mtb proteomic features using DDA
methods
Protein profiling of clinical isolate strains of Mtb has
increased the depth of our knowledge about the Mtb
proteome. Comparison of proteomic datasets on H37Rv
and H37Ra, a virulent and avirulent strain of Mtb, iden-
tified 29 significant changes of membrane associated
proteins, including the possible protein export membrane
protein SecF and three ABC-transporter proteins, that
were upregulated in H37Rv. This suggested that the
bacterial secretion and transporter systems might be
significant determinants for the virulence of the bacilli
[46]. A similar approach applied to the membrane associ-
ated proteins of H37Rv and BCG, the vaccine strain of
Mtb, revealed the significance of membrane proteins in
causing the disease. Analyzing the proteome of H37Rv,
H37Ra, BND and JAL strains highlighted the distinct
protein expression patterns of Esx and mce1 operon
proteins in the JAL and BND strain, respectively, sug-
gesting EsxA as a potential virulence factor. Proteins
MmpL4, Rv1269c, Rv3137, and SseA have been reported
as major differences between the ancient and modern
Beijing strains which might clarify the increased viru-
lence and success of the modern Beijing strains [47].
SseA, a predicted thiol-oxidoreductase, together with
SodA and DoxX constitute a membrane-associated oxi-
doreductase complex (MRC) and lack of any MRC sub-
unit results in the defective recycling of mycothiol as a
functional analog of glutathione [48,49]. The low level of
SseA in the modern Beijing strains most likely results in
increased DNA oxidation damage which explains the
higher rate of mutation and accelerated acquisition of
drug resistance compared to more ancient strains [50].
Up-regulation of enzymes responsible for long-chain fatty
acid biosynthesis and HsaA implicated in steroid degra-
dation and down-regulation of long-chain fatty acid
degrading enzymes have been observed in Beijing B0/
W148 strains in compared to the reference strain termed
H37Rv [49]. The differential expression of 23 proteinsree major modes. (a) The workflow shows the four major steps of a
on, data processing and data analysis. The significant difference
iated data analysis illustrated in panel b–d. (b) In Shotgun-MS
sity. The scheme depicts the selected precursors using asterisk signs.
M are knowledge based data acquisition methods where one has to
f interest in order to define the isolation scheme. As these methods do
 independent acquisition methods. (d) SWATH-MS divides the whole
sors attributed to a certain mass/charge range (window) are isolated
antitative proteomic data is extracted based on prior knowledge.
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clinically relevant strains showing various degrees of
pathogenicity [51]. Proteomic and transcriptional analy-
ses also generated some insights on metabolic remodeling
between different BCG strains which might be mani-
fested by various degrees of immunogenicity and poten-
tially vaccine efficacy [52]. The mycobacterial protein
analysis of mono-infected and HIV co-infected macro-
phages revealed 92 significant changes which belong to
various functional categories such as toxin–antitoxin (TA)
modules, cation transporters and type VII (Esx) secretion
systems [53].
Proteomic studies have also increased the depth of our
knowledge about the significant regulatory pathways of
Mtb. PhoP as a virulence factor regulates a small non-
coding RNA (ncRNA) namely Mcr7 which affects the
activity of the Twin Arginine Translocation (Tat) protein
secretion system through TatC modulation. Conse-
quently, the secretion of BlaC and the antigen 85 complex
(Ag85), a key player in the pathogenicity, changes signifi-
cantly [54]. To decipher the role of SecA2 dependent
export pathway, the cell wall and cytosolic proteome of a
SecA2 mutant were compared to the wild type introduc-
ing the association of the pathway with DosR regulon and
the Mce1 and Mce4 lipid transporters [55]. Proteomic
analyses of culture filtrate on Mtb revealed EsxG and
EsxH, secreted co-dependently, facilitate the secretion of
several members of the proline–glutamic acid (PE) and
proline–proline–glutamic acid (PPE) protein families
such as PE5 [56].
Drug resistant strains of Mtb are a growing problem for
healthcare systems and have been investigated using
proteomic methods. Bedaquiline (BDQ), approved for
the treatment of multidrug-resistant TB (MDR-TB),
inhibits ATP synthesis inducing a bacteriostatic state
for 3-4 days after drug exposure. The induction of the
DosR regulon as well as the activation of ATP-generating
pathways promote bacterial viability during this initial
drug exposure, explaining in part why BDQ is more
effective when the bacilli have access to only non-fer-
mentable energy sources such as lipids [57]. Studying the
proteome of ofloxacin (OFX) resistant strains showed
fourteen proteins up-regulated in respect to the OFX
susceptible strains. Further docking analysis on four of
the proteins elucidated conserved motifs and domains
interacting with OFX as a second-line drug against MDR-
TB [58]. A study showed that the abundance of several
proteins responsible for the maintenance of cell-envelope
permeability barrier changed significantly in Mtb exposed
to thioridazine. Thioridazine increases cell-envelope per-
meability and thereby facilitates components uptake [59].
The term post translational modification (PTM) refers
to the covalent modification of proteins by functional
groups such as phosphorylation which result in differentCurrent Opinion in Microbiology 2017, 39:64–72 proteoforms which may represent different functional
states of the protein. Although the mechanistic impor-
tance of PTMs in mammalian systems has been exten-
sively reported, the roles of PTMs in pathogenic bacteria,
such as Mtb, are not well explored. To date, eight types of
protein modifications have been detected in the Mtb
proteome. Our meta-analyses show that at least 30% of
the Mtb proteins undergo one or more type of PTM
(Figure 2a). Acetylation [60] and phosphorylation [61–65]
are the most common modifications in Mtb. Moreover, O-
glycosylation [66,67], pupylation (prokaryotic ubiquitin-
like protein modification) [68], lipidation [66], methyla-
tion, deamidation and N-formylation have been reported
(Figure 2b and c) [69]. Our analysis also showed that
specific types of modifications can be enriched in specific
functional categories. For instance, the lipidated proteins
are mostly implicated in the cell wall processes
(Figure 2d). Serine, threonine and tyrosine phosphoryla-
tion constitute 37%, 52% and 11% of so far identified
phosphorylated proteins, respectively, which is in a simi-
lar range in comparison with other bacteria (Table S1
contains a literature curated list of post translationally
modified proteins detected so far in Mtb — corresponds
to Figure 2). Although a tyrosine kinase with in vivo
activity has not been identified in Mtb, some of the
serine — threonine protein kinases (STPKs) revealed
also tyrosine phosphorylation activities [65].
Robust and reproducible Mtb proteome profiling using
DIA methods
With the recent developments in the DIA/SWATH-MS
field, we can quantify 2700 proteins of Mtb at semi-
high-throughput (14 samples/day) consistently from 1 mg
of total peptide mass over many samples and conditions.
To support the quantitative measurement of the Mtb
proteome by DIA/SWATH-MS, an Mtb proteome spec-
tral library has been generated, validated and made
publicly accessible [45]. It contains 97% of the anno-
tated Mtb proteins and has paved the way to study the
Mtb proteome under many different conditions. Accord-
ing to shotgun-MS and deep RNASeq experiment, we
presume that 3488 proteins are expressed in Mtb cumu-
latively and that protein concentrations range from 0.1 to
1000 fmol/mg (10–44 632 estimated protein copies per
cell), spanning four order of magnitude. GroEL1/2, MihF,
GroES and Tuf are the most abundant proteins. Further-
more, 29 previously unannotated proteins have been
identified by MS-based proteomics which emphasizes
that the genome annotation of Mtb still needs to be
further refined [45]. In a prototypical study, the absolute
protein concentrations of the Mtb proteome and its
reorganization after exposure to hypoxia was determined
in a time course experiment. The results showed that
whereas ribosomal proteins remain largely unchanged,
products of DosR regulon genes were strongly induced
to constitute 20% of the cellular protein content dur-
ing dormancy. A quarter of 631 differentially expressedwww.sciencedirect.com
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Meta-analysis on modified proteins of Mycobacterium tuberculosis. (a) Overview on modified proteins. (b) Distribution of modified proteins
according to their modification types. (c) Venn diagram shows overlap of the modified proteins with each other. (d) Contribution of modified
proteins in various functional categories.proteins had metabolic functions and 80% of them con-
stituted connected metabolic pathways with at least four
enzymes [44].
Prospective directions
Systems biology approaches have de-convoluted many
molecular mechanisms in various organisms. Given the
functional significance of proteins in biological systems,
MS-based proteomics has become a dominant method for
systematic studies at high throughput. In the case of Mtb,
a recently developed complete proteome spectral library
has facilitated proteomic measurements of the bacilli
using DIA/SWATH-MS and any targeted method.
SWATH-MS is able to quantify the bulk of the Mtb
proteome at semi-high-throughput reproducibly and sys-
tematically across samples and conditions and such a deep
and robust protein profiling brings new biologicalwww.sciencedirect.com questions to the realm of feasibility. For instance, more
than two thirds of the transcription factors in Mtb can be
quantified directly from the whole cell lysate which
would warrant various transcriptional analyses in order
to understand how transcription factors orchestrate the
Mtb transcriptional regulatory network in different con-
ditions. Since Gagneux and colleagues recently showed
that even Mtb strains belonging to the sublineages of
lineage 4 reveal different phenotypic traits, H37Rv as a
member of that lineage cannot be the representative of
Mtb clinical isolates anymore. Extending the Mtb
research from H37Rv to the clinical isolates opens new
opportunities for various types of studies. For instance,
the GWAS approach can be portable to other biomolecu-
lar layers of a cell such as the proteome to characterize the
consequence of natural genetic diversity on the proteome
and eventually various phenotypes. These types ofCurrent Opinion in Microbiology 2017, 39:64–72
70 Bacterial systems biologystudies, already implemented for other organisms, might
manifest molecular mechanisms underlying infection,
survival and persistence of Mtb.
Moving from in vitro research to the more physiologically
relevant environment of the host should be an essential
long-term goal in the field of infectious diseases. Infected
cell lines or primary cells, and mouse models can be
considered as intermediates toward the analysis of clinical
human tissue samples. The proteomic technologies
described here also support in principle the analysis of
more complex samples that would include both bacterial
and host components, however, quantifying pathogens’
proteins following infection will be challenging due to the
dilution effect of bacterial proteins into the significantly
more complex proteome of the host. The significance of
such studies underlines the need for developing new
appropriate workflows to be able to address different
biological questions through profiling clinical tissue sam-
ples more efficiently. In the ideal case, such methods
would be able to quantify both pathogen and host pro-
teomes in order to address questions in host–pathogen
interactions.
We conclude that while, until recently, systems level
research in the Mtb field has been dominated by genomic
and functional genomic approaches, with the advent of
improved methods in quantitative proteomics and
increasing experience in their application to problems
in Mtb biology, the field is beginning to benefit from more
extensive protein measurements. We expect that protein-
level information will increase the functional relevance of
systems biology studies of Mtb.
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